Resources Guide

Therapy Initiation Resources

  • QOPI Measures
    • QOPI Core13oral4 – Documented plan for oral chemotherapy (defect-free measure, Core13oral4a-Core13oral4d)
    • QOPI Core13oral4a – Documented plan for oral chemotherapy: dose
    • QOPI Core13oral4b – Documented plan for oral chemotherapy: provided to patient/caregiver prior to start of therapy and practitioner(s) providing continuing care (PCP) within 3 months of starting therapy
    • QOPI Core13oral4c – Documented plan for oral chemotherapy: indications

Education Resources

  • QOPI Measures
    • QOPI Core13oral5 – Oral chemotherapy education provided prior to the start of therapy (defect-free measure, Core13oral5a-Core13oral5c)
    • QOPI Core13oral5a – Oral chemotherapy education provided prior to the start of therapy: missed doses
    • QOPI Core13oral5b – Oral chemotherapy education provided prior to the start of therapy: toxicities
    • QOPI Core13oral5a – Oral chemotherapy education provided prior to the start of therapy: clinic contact instructions

Drug Specific Resources

Drug NamePatient
Self-management Education
PCP
Information
Video
Education for Staff
Prior Authorization Information
Abiraterone (Zytiga)PDFDOCPDFDOC
Afatinib (Gilotrif)PDFDOCPDFDOC
Alectinib (Alecensa)PDFDOCPDFDOC
Axitinib (Inlyta)PDFDOCPDFDOC
Bexarotene (Targretin)PDFDOCPDFDOC
Bosutinib (Bosulif)PDFDOCPDFDOC
Brigatinib (Alunbrig)PDFDOCPDFDOC
Cabozantinib (Cabometyx)PDFDOCPDFDOC
Capecitabine (Xeloda)PDFDOCPDFDOC
Ceritinib (Zykadia)PDFDOCPDFDOC
Chlorambucil (Leukeran)PDFDOCPDFDOC
Cobimetinib (Cotellic)PDFDOCPDFDOC
Crizotinib (Xalkori)PDFDOCPDFDOC
Cyclophosphamide (Cytoxan)PDFDOCPDFDOC
Dabrafenib (Tafinlar)PDFDOCPDFDOC
Dasatinib (Sprycel)PDFDOCPDFDOC
Enasidenib (idhifa)PDFDOCPDFDOC
Enzalutamide (Xtandi)PDFDOCPDFDOC
Erlotinib (Tarceva)PDFDOCPDFDOC
Etoposide (Etopophos, Toposar)PDFDOCPDFDOC
Everolimus (Afinitor)PDFDOCPDFDOC
Gefitinib (Iressa)PDFDOCPDFDOC
Hydroxyurea (Hydrea, Droxia)PDFDOCPDFDOC
Ibrutinib (Imbruvica)PDFDOCPDFDOC
Idelalisib (Zydelig)PDFDOCPDFDOC
Imatinib (Gleevec)PDFDOCPDFDOC
Ixazomib (Ninlaro)PDFDOCPDFDOC
Lapatinib (Tykerb)PDFDOC
Lenalidomide (Revlimid)PDFDOCPDFDOC
Lenvatinib (Lenvima)PDFDOCPDFDOC
Lomustine (CCNU, Ceenu)PDFDOCPDFDOC
Melphalan (Alkeran)PDFDOCPDFDOC
Mercaptopurine (Purinethol, Purixan)PDFDOCPDFDOC
Methotrexate (Trexall, Rasuvo)PDFDOCPDFDOC
Midostaurin (Rydapt)PDFDOCPDFDOC
Mitotane (Lysodren)PDFDOCPDFDOC
Neratinib (Nerlynx)PDFDOCPDFDOC
Nilotinib (Tasigna)PDFDOCPDFDOC
Olaparib (Lynparza)PDFDOCPDFDOC
Osimertinib (Tagrisso, Tagrix)PDFDOCPDFDOC
Palbociclib (Ibrance)PDFDOCPDFDOC
Panobinostat (Farydak)PDFDOCPDFDOC
Pazopanib (Votrient)PDFDOC
Pomalidomide (Pomalyst)PDFDOCPDFDOC
Ponatinib (Iclusig)PDFDOCPDFDOC
Procarbazine (Matulane)PDFDOCPDFDOC
Regorafenib (Stivarga)PDFDOCPDFDOC
Rucaparib (Rubraca)PDFDOCPDFDOC
Ruxolitinib (Jakafi)PDFDOC
Sonidegib (odomzo)PDFDOCPDFDOC
Sorafenib (Nexavar)PDFDOCPDFDOC
Sunitinib (Sutent)PDFDOCPDFDOC
Temozolomide (Temodar)PDFDOCPDFDOC
Thalidomide (Thalomid)PDFDOCPDFDOC
Thioguanine (Tabloid)PDFDOCPDFDOC
Topotecan (Hycamtin)PDFDOCPDFDOC
Trametinib (Mekinist)PDFDOCPDFDOC
Tretinoin (Refissa, Atralin, Tretin-X, Retin-A, Avita, and Renova)PDFDOCPDFDOC
Vandetanib (Caprelsa)PDFDOCPDFDOC
Vemurafenib (Zelboraf)PDFDOCPDFDOC
Venetoclax (Venclexta)PDFDOCPDFDOC
Vismodegib (Erivedge)PDFDOCPDFDOC
Vorinostat (Zolinga)PDFDOCPDFDOC

Monitoring Resources

  • QOPI Measures

    • QOPI Core13oral6 – Oral chemotherapy monitored on visit/contact following start of therapy (defect-free measure, Core13oral6a-Core13oral6b)
    • QOPI Core13oral6a – Oral chemotherapy monitored on visit/contact following start of therapy: medication adherence assessed
    • QOPI Core13oral6b – Oral chemotherapy monitored on visit/contact following start of therapy: medication adherence addressed